alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. 

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Career Development Grant Review.                    

*Date:*                         June 17, 2010.                    

*Time:*                         10:30 a.m. to 12:30 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                     

*Place:*                         National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20817 (Telephone Conference Call).                    

*Contact Person:*                         Quirijn Vos, PhD, Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, NIH/NIAID/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892, 301-451-2666,                         *qvos@niaid.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

Dated: May 19, 2010.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 2010-12545 Filed 5-24-10; 8:45 am]

BILLING CODE 4140-01-P
#### Samuel J. Roth, M. D., P. C., Plaintiff, v Amica Mutual Ins. Co. et al., Defendants.

District Court of Suffolk County, Third District,

April 9, 1987

APPEARANCES OF COUNSEL

*Armstrong & Butterfield (Kenneth C. Butterfield*of counsel), for plaintiff. *Robert R. Serpe, P. C.,*for defendant.

OPINION OF THE COURT

Rockwell D. Colaneri, J.

The plaintiff sues for $1,475.97 for services rendered to Nancy Fordon and on an assignment of first-party benefits under a no-fault auto policy with Arnica Mutual Insurance Company. At the trial of this case, the plaintiff agrees that $41.21 was an overbilling and the amount sued for is reduced to $1,434.76. Further, the cause of action against the patient *131for services rendered must be dismissed pursuant to Insurance Law § 5108 (c). The health provider is limited to the payments under Insurance Law § 5108 (a) and (b) when treating a no-fault patient. *(See, Roth v Hanover Ins. Co.,*126 Misc 2d 347.)

The amount of money sued for represents the difference between the amount permissible under schedules of medical fees as interpreted by the plaintiff, health provider and the amount as interpreted by the no-fault insurer. The language to be interpreted is found in 11 NYCRR appendix 17-A, in the fifth paragraph of the subheading "Surgery”: "For unrelated procedures performed at the same time, payment is for the procedure with the highest allowance plus half of the lesser procedures up to a maximum of twice the highest fee.”

The hospital record indicates the following injuries:

"a. 2” laceration, avulsion injury extending from the oral mucosa on the left side through the white line of the left side through the commissure onto the left side of the cheek extending through the skin, subcutaneous tissue, muscles and upper face and orbicularis muscle;

"b. a 1” irregular laceration, avulsion of the lower lip located medially;

"c. *3¥2"*long laceration by *IV2"*wide extending from the lateral right side of the upper labium of mucosa across the midline onto the left inner upper cheek and extending through mucosa and muscle of the face with complete avulsion of the degloving of the maxilla up to the orbital rim and left side nasal bones with a large hole located along the nasal maxillary plate.”

The plaintiff performed plastic surgery on each one of these wounds on March 31, 1985. This court finds that the plaintiff performed three independent procedures sequentially, on the same date, though not at the same time. The plaintiff is entitled to payment for each procedure and the above-cited language of appendix 17-A is inapplicable.

Accordingly, judgment of $1,434.76 is awarded to the plaintiff. Pursuant to 11 NYCRR 65.15 (g) the above sum was overdue on June 1, 1985 and plaintiff is entitled to "two percent [interest] per month, compounded and calculated on a pro rata basis using a 30-day month.” Further, pursuant to 11 NYCRR 65.15 (h) the plaintiff is entitled to attorney’s fees of $55.
[Federal Register Volume 75, Number 97 (Thursday, May 20, 2010)]
[Notices]
[Page 28261]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-12143]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the Center for 
Scientific Review Special Emphasis Panel, June 4, 2010, 2 p.m. to June 
4, 2010, 4 p.m., Grand Hyatt Seattle, 721 Pine Street, Seattle, WA 
98101 which was published in the Federal Register on May 11, 2010, 75 
FR 26261-26262.
    The meeting has been changed to a telephone assisted meeting at the 
National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 
20892. The meeting date and time have been changed to June 11, 2010, 
from 1 p.m. to 2 p.m. The meeting is closed to the public.

    Dated: May 14, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-12143 Filed 5-19-10; 8:45 am]
BILLING CODE 4140-01-P
13

Case: 19-30088    Doc# 1985    Filed: 05/13/19    Entered: 05/13/19 11:40:17    Page 1 of1
1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

 UNITED STATES BANKRUPTCY COURT 

NORTHERN DISTRICT OF CALIFORNIA 

SAN FRANCISCO DIVISION 

In re: 

PG&E CORPORATION, 

- and -

PACIFIC GAS AND ELECTRIC 

COMPANY, 

Reorganized Debtors. 

Bankruptcy Case 

No. 19-30088 (DM) 

Chapter 11 

(Lead Case) 

(Jointly Administered) 

CERTIFICATE OF SERVICE 

I, Liz Santodomingo, do declare and state as follows: 

1. I am employed by Kroll Restructuring Administration LLC (“Kroll”)1, the claims and

noticing agent for the Reorganized Debtors in the above-referenced chapter 11 bankruptcy cases.

2. On August 30, 2022, at my direction and under my supervision, employees of Kroll

caused the following documents to be served via First Class Mail on Roy A. Bissember Address 

ID 4216224 at an address redacted in the interest of privacy: 

 Settlement Agreement Bankruptcy Claim 91784

 Form W-9

3. I have reviewed the Notices of Electronic Filing (NEF) for the above-listed documents,

and I understand that parties listed in each NEF as having received notice through electronic mail were 

electronically served with that document through the Court’s Electronic Case Filing system. 

4. I declare under penalty of perjury under the laws of the United States of America, that

the foregoing is true and correct and that if called upon as a witness, I could and would competently 

testify thereto. 

1

 Effective March 29, 2022, Prime Clerk LLC changed its name to Kroll Restructuring Administration LLC. 

Case: 19-30088 Doc# 12940 Filed: 09/08/22 Entered: 09/08/22 16:23:49 Page 1

of 2
1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

2 SRF 63733 

Executed this 7th day of September 2022, at New York, NY. 

/s/ Liz Santodomingo

Liz Santodomingo

Case: 19-30088 Doc# 12940 Filed: 09/08/22 Entered: 09/08/22 16:23:49 Page 2

of 2
EXHIBIT 32.1



CERTIFICATE PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly Report on Form 10-Q for the three and six months ended June 30, 2003, of Commercial Federal Corporation as filed with the
Securities and Exchange Commission on August 8, 2003 (the Report), I, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 that, to my knowledge, the Report fully
complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Commercial
Federal Corporation.



Date: August 8, 2003



By:

/s/ William A. FitzgeraldWilliam A. FitzgeraldChairman of the Board and Chief Executive Officer




/s/ David S. FisherDavid S. FisherExecutive Vice President and Chief Financial Officer




A signed
original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this
written statement required by Section 906, has been provided to Commercial Federal Corporation and will be retained by Commercial Federal Corporation and furnished to the Securities and Exchange Commission or its staff upon request.



42
This memorandum opinion was not selected for publication in the New Mexico Reports. Please see

Rule 12-405 NMRA for restrictions on the citation of unpublished memorandum opinions. Please

also note that this electronic memorandum opinion may contain computer-generated errors or other

deviations from the official paper version filed by the Court of Appeals and does not include the

filing date. 

1 IN THE COURT OF APPEALS OF THE STATE OF NEW MEXICO

2 STATE OF NEW MEXICO,

3 Plaintiff-Appellee,

4 v. No. 31,671

5 AARON J. UPCHURCH,

6 Defendant-Appellant.

7 APPEAL FROM THE DISTRICT COURT OF SAN JUAN COUNTY

8 John A. Dean, District Judge

9 Gary K. King, Attorney General 

10 M. Victoria Wilson, Assistant Attorney General

11 Santa Fe, NM

12 for Appellee

13 Jacqueline Cooper, Chief Public Defender

14 Adrianne R. Turner, Assistant Appellate Defender

15 Santa Fe, NM 

16 for Appellant

17 MEMORANDUM OPINION

18 BUSTAMANTE, Judge.
2

1 Defendant-Appellant Aaron Upchurch (Defendant) has appealed his convictions

2 for larceny, burglary, conspiracy to commit larceny, and conspiracy to commit

3 burglary. On May 2, 2012, we issued a second notice of proposed summary

4 disposition, proposing to affirm in part and reverse in part. The State has filed a

5 response with this Court indicating that it does not oppose our analysis. Defendant

6 has also filed a memorandum in response in which he indicates that he substantially

7 agrees, while renewing his claim of ineffective assistance of counsel. With respect to

8 this claim, Defendant advances no new argument. We therefore remain unpersuaded.

9 Accordingly, for the reasons stated in the second notice of proposed summary

10 disposition, we affirm Defendant’s convictions for larceny, burglary, and conspiracy

11 to commit larceny. We reverse Defendant’s conviction for conspiracy to commit

12 burglary, as well as the habitual offender sentence enhancement, and remand for

13 further proceedings consistent herewith.

14 IT IS SO ORDERED.

15 

16 MICHAEL D. BUSTAMANTE, Judge

17 WE CONCUR:

18 

19 JAMES J. WECHSLER, Judge
3

1 

2 RODERICK T. KENNEDY, Judge
Exhibit 32.1





CERTIFICATIONS OF THE PRESIDENT AND CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with the Quarterly Report of Nutrition 21, Inc., a New York corporation (the “Company”), on Form 10-Q for the quarter ended March 31, 2011, as filed with the Securities and Exchange Commission (the “Report”), Michael A. Zeher, Chief Executive Officer of the Company, does hereby certify, pursuant to § 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. § 1350), that to his knowledge:





(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.





/s/     Michael A. ZeherMichael A. Zeher

President and Chief Executive Officer


May 13, 2011




A signed original of this written statement required by Section 906 has been provided to Nutrition 21, Inc. and will be retained by Nutrition 21, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
<PAGE>


                                                                    Exhibit 31.2


CERTIFICATIONS  OF THE CHIEF  FINANCIAL  OFFICER  PURSUANT TO SECTION 302 OF THE
SARBANES-OXLEY ACT OF 2002

CERTIFICATIONS

I, Paul Intlekofer, certify that:

1. I have reviewed this quarterly report on Form 10-Q/A of Nutrition 21, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact  necessary to make the statements
made, in light of the  circumstances  under which such statements were made, not
misleading with respect to the period covered by this report;

3.  Based  on my  knowledge,  the  financial  statements,  and  other  financial
information included in this report, fairly present in all material respects the
financial  condition,  results of operations and cash flows of the registrant as
of, and for, the periods presented in this report;

4.  The  registrant's  other  certifying  officer  and  I  are  responsible  for
establishing and maintaining  disclosure  controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a) Designed such disclosure  controls and procedures,  or caused such disclosure
controls and  procedures to be designed  under our  supervision,  to ensure that
material  information  relating to the  registrant,  including its  consolidated
subsidiaries, is made known to us by others within those entities,  particularly
during the period in which this report is being prepared;

b) Evaluated  the  effectiveness  of the  registrant's  disclosure  controls and
procedures and presented in this report our conclusions  about the effectiveness
of the disclosure  controls and procedures,  as of the end of the period covered
by this report based on such evaluation; and

c) Disclosed in this report any change in the registrant's internal control over
financial  reporting that occurred  during the  registrant's  most recent fiscal
quarter (the registrant's fourth fiscal quarter in the case of an annual report)
that has materially affected,  or is reasonably likely to materially affect, the
registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed,  based on our
most recent  evaluation of internal  control over  financial  reporting,  to the
registrant's auditors and the audit committee of registrant's board of directors
(or persons performing the equivalent functions):

a) All  significant  deficiencies  and  material  weaknesses  in the  design  or
operation of internal  control over  financial  reporting  which are  reasonably
likely  to  adversely  affect  the  registrant's  ability  to  record,  process,
summarize and report financial information; and

b) Any  fraud,  whether  or not  material,  that  involves  management  or other
employees who have a significant role in the registrant's  internal control over
financial reporting.


Date: December 24, 2003

Paul Intlekofer
Chief Financial Officer


                                       22
<PAGE>
                                                                    Exhibit 31.2

CERTIFICATIONS

I, Michael Giordano, certify that:

1. I have reviewed this Four Month Report on Form 10-Q of Fedders Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as
of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

      a) Designed such disclosure controls and procedures, or caused such
      disclosure controls and procedures to be designed under our supervision,
      to ensure that material information relating to the registrant, including
      its consolidated subsidiaries, is made known to us by others within those
      entities, particularly during the period in which this report is being
      prepared;

      b) Evaluated the effectiveness of the registrant's disclosure controls and
      procedures and presented in this report our conclusions about the
      effectiveness of the disclosure controls and procedures, as of the end of
      the period covered by this report based upon such evaluation; and

      c) Disclosed in this report any change in the registrant's internal
      control over financial reporting that occurred during the registrant's
      most recent four month period ended December 31, 2003 (the registrant's
      fourth fiscal quarter in the case of an annual report) that has materially
      affected, or is reasonably likely to materially affect, the registrant's
      internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on
our most recent evaluation of internal control over financial reporting, to the
registrant's auditors and the audit committee of the registrant's board of
directors (or persons performing the equivalent functions):

      a) All significant deficiencies and material weaknesses in the design or
      operation of internal control over financial reporting which are
      reasonably likely to adversely affect the registrant's ability to record,
      process, summarize and report financial information; and

      b) Any fraud, whether or not material, that involves management or other
      employees who have a significant role in the registrant's internal control
      over financial reporting.

Date: February 13, 2004

/s/ Michael Giordano
-----------------------
Michael Giordano
Chief Financial Officer


                                       27
* Pursuant to 5TH CIR. R. 47.5, the court has determined that this opinion should not

be published and is not precedent except under the limited circumstances set forth in 5TH CIR.

R. 47.5.4.

IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 07-10838

Conference Calendar

UNITED STATES OF AMERICA

Plaintiff-Appellee

v.

RICK SMIRL

Defendant-Appellant

Appeal from the United States District Court

for the Northern District of Texas

USDC No. 4:07-CR-3-15

Before PRADO, OWEN, and SOUTHWICK, Circuit Judges.

PER CURIAM:*

The attorney appointed to represent Rick Smirl has moved for leave to

withdraw and has filed a brief in accordance with Anders v. California, 386 U.S.

738 (1967). Smirl has not filed a response. Our independent review of the

record and counsel’s brief discloses no nonfrivolous issue for appeal.

Accordingly, counsel’s motion for leave to withdraw is GRANTED, counsel is

excused from further responsibilities herein, and the APPEAL IS DISMISSED.

See 5TH CIR. R. 42.2.

United States Court of Appeals

Fifth Circuit

F I L E D

April 16, 2008

Charles R. Fulbruge III

Clerk
[Federal Register Volume 75, Number 98 (Friday, May 21, 2010)]
[Notices]
[Page 28622]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-12174]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Conducting Public Health Research in Kenya 
(U01)(Panel A), Funding Opportunity Announcement (FOA) GH10-003, 
Initial Review

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

Time and Date: 1 p.m.-5 p.m., June 29, 2010 (Closed).

Place: Teleconference.

Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., 
and the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.

Matters to be Discussed: The meeting will include the initial review, 
discussion, and evaluation of applications received in response to 
``Conducting Public Health Research in Kenya (U01)(Panel A),'' FOA 
GH10-003.

Contact Person for More Information: Susan Stanton, D.D.S., Scientific 
Review Officer, CDC, 1600 Clifton Road, NE., Mailstop D74, Atlanta, GA 
30333, Telephone: (404) 639-4640.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both CDC and the Agency for Toxic Substances and Disease Registry.

    Dated: May 6, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2010-12174 Filed 5-20-10; 8:45 am]
BILLING CODE 4163-18-P
#### Pametta Mullen, an Infant by Guardian. Respondent, v. Asbury Christian, Appellant, Impleaded, etc.

— Judgment and order affirmed. Opinion by

Bradley.J.